CCL2 and psoriasis vulgaris: reported that granulocyte-macrophage colony-stimulating factor and IL-4 enhanced OSM expression in isolated human monocytes, with higher levels of CCL2 expression in the skin lesions of AD and psoriasis vulgaris (9).